Hgh Plus   

hGH releasing formula breakthrough!


Bookmark Dr. Orman's Human Growth Hormone Satellite site!

 

Home
Order Here

Clinical Trials
Trials II
Safety Data
A Must Read
Comparison
Ingredients
Homeopathic hGH?
Avoiding Mega Doses
Releasers
HGH Highlights
Reasons for HGH
Press Release
Need for Balance
Testimonials
FAQ
Developer

Clinical Trials Results: #218-1

Dr. Orman's Human Growth Hormone Releaser

Introduction:

The product, Dr. Orman's Hgh Plus® from DMI, is an all-natural secretagogue designed to stimulate the pituitary gland to release human growth hormone. Clinical trials which commenced on June 10, 1998, testing for the effectiveness, were completed. Below is a summary of the results:

Data

Name of Product tested: Hgh Plus® (Dr. David Orman’s Human Growth Hormone releaser)

Type of trial: Clinical; M.D. supervised

Location: Florida (USA)

Major focus of trial: IGF-1Levels

Secondary focus: Biomarkers

Number of participants: 10

Compliance: 100%

Reported side-effects/Complaints: none

Observed/Measured side-effects: none

Number of Participants whose Somatomedin C levels increased: 10 of 10

Average Somatomedin C* increase: 71.186% 

* Somatomedin C, also called Insulin growth factor-1 (IGF-1) is a protein produced by the liver via Human Growth Hormone. By testing Somatomedin C levels (through a blood test by the same name),  accurate marker of how much GH the body is secreting is attained.

Average Time Frame: 60 days

Summary: The product yielded an average increase in Somatomedin C levels of 71.186% over an average period of 60.8 days in all participants.

Conclusion: The product is an effective Growth Hormone releasing agent as evidenced by the clinical results.

Commentary: Click Here

 

Dezine Management (DMI). . . Dr. Orman's only Fulfillment and Information Center for Hgh.Plus®!

 

©2007. No one may copy/reproduce material on this website without express written consent of DMI. Product not intended to treat, diagnose or cure illness. No claims, medical or otherwise  are made.